2019 News

10.18.2019 Press Release

Santen Donates to the Disaster Caused by Typhoon Hagibis

09.20.2019 Press Release

Receipt of NDA Approval of Alesion LX for anti-allergy in Japan, and Joint Sales Promotion Contract with Mitsubishi Tanabe Pharma

09.06.2019 Press Release

Sponsorship Agreement for IBSA Blind Football Asian Championships 2019 signed between Santen, IBF Foundation, and JBFA

08.30.2019 Press Release

Santen Announces Topline Pivotal Data for DE-128 (MicroShunt) Demonstrating Reductions in Intraocular Pressure and Medication Use in Patients

08.01.2019 Press Release

Santen Reports the 1st Quarter Fiscal 2019 Consolidated Performance

07.24.2019 Press Release

Notice on the Completion of Disposal of Treasury Shares Under Restricted Stock-Linked Remuneration Program

07.03.2019 Press Release

Santen Included in All Four ESG Investment Indices Selected by GPIF

06.26.2019 Information

Corporate Social Responsibility (CSR) page on our website has been updated

06.26.2019 Press Release

Oxford Biomedica and Santen enter R&D collaboration and Option & Licence Agreement for development of gene therapy vectors for inherited retinal disea

06.25.2019 Press Release

Notice on the Disposal of Treasury Shares Under Restricted Stock-Linked Remuneration Program

06.11.2019 Press Release

Santen Chooses SAP S/4HANA Cloud and Other SAP Solutions to Reform Key Operation System and Strengthen Global Management Structure

05.09.2019 Press Release

Santen Reports Fiscal 2018 Consolidated Performance

05.09.2019 Press Release

Notice of Board of Director and Corporate Auditor Nominations

04.26.2019 Press Release

Santen and Glaukos Enter into Collaboration and Distribution Agreement for Exclusive Distribution of the MicroShunt (DE-128) in the United States

04.18.2019 Press Release

Santen Announces Launch of LENTIS Comfort, Low-Add Segmental Intraocular Lens for Cataract Treatment in Japan

03.27.2019 Press Release

Santen Announces Cancellation of Treasury Shares

03.25.2019 Press Release

Santen Announces Completion of Repurchase of Own Shares

03.13.2019 Press Release

Notice of Corporate Officer Appointments

03.08.2019 Press Release

Santen to Conduct Activities to Raise Disease Awareness during World Glaucoma Week, March 10 to 16

03.06.2019 Press Release

Santen Selected and Launches Photo-Crosslinking Research and Development Project for Pathologic Myopia Treatment for CiCLE Program

03.06.2019 Press Release

Santen Selected and Launches Gene Therapy Drug Research and Development Project for Inherited Ocular Disease Treatment for CiCLE Program

03.01.2019 Press Release

Santen Announces Status of Repurchase of Own Shares

02.20.2019 Press Release

Santen Announces Repurchase of Own Shares

02.05.2019 Press Release

Santen Reports the 3rd Quarter Fiscal 2018 Consolidated Performance

01.31.2019 Press Release

Santen Hosts Event to Raise Public Awareness of Importance of Continued Glaucoma Treatment Prior to Sponsoring World Glaucoma Week in March

01.25.2019 Press Release

Santen's Tampere manufacturing facility to be acquired by NextPharma

01.08.2019 Press Release

Santen Updates Pipeline in Corporate Presentation of January 8, 2019